Cointime

Medivate Partners

investment firm

About

Medivate Partners LLC is an investment arm of Posco specializing in cross border, growth capital, early stage and mid stage.

Highlights

Investments
5
Lead Investments
1
Exits
2
Employee Profiles
1

Details

Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
5
1
Medivate Partners has made 5 investments. Their most recent investment was on Jun 26, 2020, when Artiva Biotherapeutics raised $78M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 26, 2020 Artiva Biotherapeutics
Series A $78M Biotechnology —
Jan 22, 2020 Cognate BioServices
Series B — Biotechnology —
Jun 18, 2018 WindMIL Therapeutics
Series B $32.50M Biotechnology —
Feb 20, 2018 Cognate BioServices
Series Unknown — Biotechnology —
Mar 21, 2016 SillaJen
Series Unknown $12M Biotechnology Yes

Employee Profiles

Number of Employee Profiles
1
Medivate Partners has 1 current employee profiles, including Executive Paul Kim
Paul Kim
Executive

Exits

Medivate Partners has had 2 exits. Medivate Partners most notable exits include Cognate BioServices ,   SillaJen

Date Company Name Exit Type Industry
Feb 17, 2021 Cognate BioServices M&A Biotechnology Detail
Dec 8, 2016 SillaJen IPO Biotechnology Detail
Cointime
Chủ Đề
Công Ty